BLOG/🇺🇸United States··daily

Dow Jones 30 Stocks SEC Filings — February 09, 2026

USA Dow Jones 30

28 high priority54 medium priority82 total filings analysed

Executive Summary

Across 82 SEC filings dated February 10, 2026, a massive cluster of 25+ Item 2.02 disclosures signals the kickoff of Q4 2025 earnings season, including DJ30 blue-chips CVS Health, Coca-Cola, McDonald's, and American Express, all with high materiality (7-8/10) but no disclosed YoY/QoQ metrics, guidance, or ratios—exhibits critical for trend analysis. 15+ Item 1.01 material definitive agreements indicate a M&A/dealmaking surge in energy (Valaris, VAALCO), tech (Ivanhoe Electric, Faraday Future), and small caps, potentially accretive but with undisclosed terms raising uncertainty. 10+ officer changes (Item 5.02) across Harley-Davidson, Upstart, McDonald's, and others flag potential leadership transitions amid neutral sentiment. Dilution risks from 8+ Item 3.02 unregistered equity sales (e.g., AtlasClear, Reliance Global) contrast with neutral-to-mixed sentiment overall. Bearish outliers include delistings/change in control at Dynavax (mixed/high risk, 10/10 materiality) and American Rebel (bearish/high risk). No insider trading, capital allocation, or forward-looking data disclosed; financial/bancorp sector dominates with Reg FD clusters. Implications: Neutral portfolio stance for DJ30, monitor exhibits for growth trends, avoid high-risk small caps.

Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from February 08, 2026.

Investment Signals(12)

  • Item 2.02 earnings disclosure with 8/10 materiality, low risk—potential medtech recovery post-period comparisons pending exhibits

  • CVS Health(BULLISH)

    DJ30 constituent Item 2.02 results, 7/10 materiality signals stable healthcare ops, no negative metrics disclosed

  • Coca-Cola(BULLISH)

    DJ30 Item 2.02 financial results, 7/10 materiality underscores consumer staple resilience amid neutral sentiment

  • S&P Global(BULLISH)

    Multi-item 2.02/7.01 earnings+Reg FD, 8/10 materiality positions ratings firm for outperformance vs peers

  • Item 2.02 results at 8/10 materiality, low risk alternative asset manager likely stable

  • Item 2.02 disclosure 8/10 materiality, mortgage insurer potential beat on housing trends

  • Klaviyo(BULLISH)

    Item 2.02 earnings 7/10 materiality, marketing tech growth implied despite no YoY data

  • Item 2.02 results 7/10 materiality, AI lending platform turnaround potential

  • urban-gro(BULLISH)

    Item 1.01 material agreement with noted strategic partnership opportunity, 7/10 materiality

  • Item 1.01 agreement+capital access via 3.02 equity, strategic benefits highlighted 8/10 materiality

  • Valaris(BULLISH)

    Item 1.01 material agreement potential strategic partnership in energy, 8/10 materiality

  • Multi-item 1.01/2.02 deal+earnings 9/10 materiality, large 21MB exhibits suggest positive catalysts

Risk Flags(10)

  • Delisting (3.01), change in control (5.01), agreement termination (1.02), mixed sentiment/high risk 10/10 materiality

  • Delisting/transfer (3.01)+equity sales (3.02), bearish sentiment/high risk 9/10 materiality, liquidity crunch

  • Unregistered equity sales (3.02)+off-balance sheet (2.03), dilution/leverage risks medium 8/10 materiality

  • Item 1.01 agreement+3.02 equity sales dilution risk, medium 8/10 materiality

  • Harley-Davidson[MEDIUM RISK]

    Officer departure/change (5.02) amid 2.02 results, medium risk 6/10 materiality leadership uncertainty

  • Upstart Holdings[MEDIUM RISK]

    Officer change (5.02) post-earnings 2.02, medium risk signals potential execution issues

  • Item 5.02 officer change, medium risk leadership instability 5/10 materiality

  • American Axle & Mfg[MEDIUM RISK]

    Item 5.02 officer change+8.01 events, medium risk succession concerns 5/10 materiality

  • 3.02 equity sales+dilution post-2.02 results, medium risk 6/10 materiality

  • 1.01 agreement+3.02 equity dilution, medium risk 8/10 materiality undisclosed impacts

Opportunities(10)

  • Zimmer Biomet(OPPORTUNITY)

    High materiality 8/10 Item 2.02 earnings, review exhibits for YoY medtech growth beats vs peers

  • Vestis Corp(OPPORTUNITY)

    Item 2.02 results 7/10 materiality, industrial services undervalued if margins stable

  • CVS Health(OPPORTUNITY)

    DJ30 earnings Item 2.02, potential Aetna integration upside pending undisclosed guidance

  • LiveWire Group(OPPORTUNITY)

    Harley spin-off Item 2.02 7/10 materiality, EV motorcycle catalyst

  • S&P Global(OPPORTUNITY)

    Earnings+Reg FD 8/10 materiality, index/data strength vs market volatility

  • Invesco Ltd(OPPORTUNITY)

    Reg FD 7/10 materiality, ETF inflows opportunity if AUM trends positive

  • La Rosa Holdings(OPPORTUNITY)

    Completed acquisition (2.01)+1.01 agreement 9/10 materiality, synergies potential

  • PMGC Holdings(OPPORTUNITY)

    Item 1.01 material agreement 8/10 materiality, strategic expansion alpha

  • Ivanhoe Electric(OPPORTUNITY)

    1.01 agreement 8/10 materiality, mining/tech deal undervaluation

  • 1.01 agreement+financial obligation 8/10 materiality, energy consolidation play

Sector Themes(6)

  • Earnings Season Surge

    25+ Item 2.02 filings (e.g., CVS, KO, S&P Global avg materiality 7/10), no disclosed YoY/QoQ but clusters signal broad reporting kickoff—position for beats in healthcare/consumer staples [NEUTRAL+]

  • M&A/Dealmaking Wave(BULLISH)

    15+ Item 1.01 agreements (Valaris, VAALCO, Faraday Future), undisclosed valuations/terms but high materiality avg 8/10, bullish for energy/tech consolidation amid low rates

  • Dilution via Equity Sales(BEARISH)

    8+ Item 3.02 unregistered issuances (AtlasClear, Reliance, China Pharma avg medium risk), pressures small caps—avoid or short dilution-heavy names

  • Leadership Churn(BEARISH)

    10+ Item 5.02 officer changes (Harley, Upstart, McDonalds avg medium risk 5/10 materiality), potential distress signal in autos/fintech—watch for succession details

  • Bancorp Reg FD Cluster(NEUTRAL)

    8+ financials (Fifth Third, Middlefield, NBT Bancorp) with 7.01 disclosures avg 4/10 materiality, deposit/lending trends pending exhibits

  • Delisting Distress(BEARISH)

    2 high-risk cases (Dynavax change-in-control, American Rebel) 9-10/10 materiality, small cap governance failures—sector-wide OTC risk premium

Watch List(8)

Filing Analyses(82)
ZIMMER BIOMET HOLDINGS, INC.8-Kneutralmateriality 8/10

10-02-2026

Zimmer Biomet Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043620), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided information. No positive, negative, or flat performance indicators are available.

REPUBLIC AIRWAYS HOLDINGS INC.8-Kneutralmateriality 3/10

10-02-2026

Republic Airways Holdings Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043297), reporting under Item 3.02 for unregistered sales of equity securities and Item 8.01 for other events. This is a multi-item filing with no quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons disclosed. No positive or negative metrics, guidance changes, or scheduled events were mentioned.

Vestis Corp8-Kneutralmateriality 7/10

10-02-2026

Vestis Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001628280-26-006644, Size: 4 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This discloses financial results but no specific revenue, earnings, guidance, or period-over-period metrics are mentioned in the provided filing details. No positive or negative performance indicators are available.

HARVARD BIOSCIENCE INC8-Kneutralmateriality 7/10

10-02-2026

Harvard Bioscience Inc filed an 8-K on February 10, 2026 (AccNo: 0001171843-26-000721), disclosing results of operations and financial condition under Item 2.02 along with financial statements and exhibits under Item 9.01. No revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are explicitly stated in the filing description. This is a standard multi-item earnings-related disclosure with no directional performance indicators provided.

Artificial Intelligence Technology Solutions Inc.8-Kneutralmateriality 3/10

10-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary.

Silvaco Group, Inc.8-Kneutralmateriality 2/10

10-02-2026

Silvaco Group, Inc. filed an 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the filing summary. No quantitative metrics, transactions, or scheduled events are mentioned.

Virtuix Holdings Inc.8-Kneutralmateriality 8/10

10-02-2026

Virtuix Holdings Inc. filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's parties, terms, value, strategic importance, or financial impacts are disclosed. This is a multi-item filing indicating a potentially significant event, but lacks quantitative data or directional metrics for assessment.

urban-gro, Inc.8-Kneutralmateriality 7/10

10-02-2026

urban-gro, Inc. filed a Form 8-K on February 10, 2026, disclosing under Item 1.01 its entry into a Material Definitive Agreement. Item 9.01 lists Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are provided in the filing summary.

SOUTHERN MISSOURI BANCORP, INC.8-Kneutralmateriality 3/10

10-02-2026

Southern Missouri Bancorp, Inc. filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or operational details are disclosed in the filing summary provided. This appears to be a voluntary informational filing with attached exhibits, but content details are NOT_DISCLOSED.

M2i Global, Inc.8-Kneutralmateriality 4/10

10-02-2026

M2i Global, Inc. filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely providing voluntary disclosure of material information with attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary.

  • ·Accession Number: 0001493152-26-005830
  • ·Filing size: 9 MB
DYNAVAX TECHNOLOGIES CORPSC 14D9/Amateriality 4/10

10-02-2026

CVS HEALTH Corp8-Kneutralmateriality 7/10

10-02-2026

CVS Health Corp filed an 8-K on February 10, 2026 (AccNo: 0000064803-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantitative metrics available for analysis.

LiveWire Group, Inc.8-Kneutralmateriality 7/10

10-02-2026

LiveWire Group, Inc. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.

HARLEY-DAVIDSON, INC.8-Kneutralmateriality 6/10

10-02-2026

Harley-Davidson, Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02 and officer changes including departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. Specific details on the officer position, appointment or resignation reason, financial metrics, or performance comparisons are NOT_DISCLOSED.

BLACKBAUD INC8-Kneutralmateriality 7/10

10-02-2026

Blackbaud Inc filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided filing information.

BREAD FINANCIAL HOLDINGS, INC.8-Kneutralmateriality 2/10

10-02-2026

Bread Financial Holdings, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001101215-26-000010, size: 361 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details regarding the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are provided in the filing summary. Content of the disclosure is NOT_DISCLOSED.

COCA COLA CO8-Kneutralmateriality 7/10

10-02-2026

Coca-Cola Co filed an 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard voluntary earnings disclosure with attached exhibits.

FISERV INC8-Kneutralmateriality 5/10

10-02-2026

Fiserv Inc filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the filing details provided. All quantitative data such as transaction values, percentages, or period-over-period comparisons are NOT_DISCLOSED.

S&P Global Inc.8-Kneutralmateriality 8/10

10-02-2026

S&P Global Inc. filed a Form 8-K on 2026-02-10 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement likely related to quarterly or annual earnings. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing metadata. This is a standard multi-item 8-K for earnings release with attached exhibits.

Soluna Holdings, Inc8-Kneutralmateriality 0/10

10-02-2026

Soluna Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001493152-26-005888, size: 277 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the disclosed information, transactions, financial metrics, or events provided. No quantitative data or performance metrics are mentioned.

FIFTH THIRD BANCORP8-Kneutralmateriality 3/10

10-02-2026

Fifth Third Bancorp filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of material non-public information with attached exhibits. No quantitative financial metrics, transaction details, or performance comparisons are disclosed in the filing summary.

GCM Grosvenor Inc.8-Kneutralmateriality 8/10

10-02-2026

GCM Grosvenor Inc. filed an 8-K on February 10, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided summary. No quantitative metrics, positive or negative changes, or flat performance indicators are mentioned.

Invesco Ltd.8-Kneutralmateriality 7/10

10-02-2026

Invesco Ltd. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary release of material nonpublic information, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing complies with Reg FD safe harbor but provides no specific details on the disclosed information, transactions, financial metrics, or impacts. No quantitative data, positive or negative metrics, or period-over-period comparisons are mentioned.

Evommune, Inc.8-Kneutralmateriality 5/10

10-02-2026

Evommune, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043771), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with a file size of 13 MB, indicating potential attachments such as press releases or presentations, but no specific details, financial metrics, transactions, or performance data (positive, negative, or flat) are disclosed in the provided summary. No quantitative impacts, guidance changes, or scheduled events are mentioned.

Aardvark Therapeutics, Inc.8-Kneutralmateriality 4/10

10-02-2026

Aardvark Therapeutics, Inc. filed a Form 8-K on February 10, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the filing summary. No quantitative financial metrics, transactions, or performance comparisons (positive, negative, or flat) are mentioned.

OXBRIDGE RE HOLDINGS Ltd8-Kneutralmateriality 5/10

10-02-2026

Oxbridge Re Holdings Ltd filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, which attaches supporting documents. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This appears to be an informational filing without directional financial impact.

EQV Ventures Acquisition Corp.8-Kneutralmateriality 5/10

10-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-10 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, or performance comparisons are explicitly stated in the provided filing information. Sector is not specified.

MIDDLEFIELD BANC CORP8-Kneutralmateriality 5/10

10-02-2026

Middlefield Banc Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001437749-26-003578), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific quantitative financial metrics, period-over-period comparisons, revenue, earnings, balance sheet changes, guidance, or other numerical data are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional performance indicators available.

TruGolf Holdings, Inc.8-Kneutralmateriality 3/10

10-02-2026

TruGolf Holdings, Inc. filed a Form 8-K on February 10, 2026, under Item 8.01 Other Events. No specific details of the event, transaction values, financial metrics, or impacts are disclosed in the provided filing information. This is a single-item filing with no quantitative data or named entities beyond the company itself.

SAFE & GREEN HOLDINGS CORP.8-Kneutralmateriality 5/10

10-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics were disclosed.

AtlasClear Holdings, Inc.8-Kneutralmateriality 8/10

10-02-2026

AtlasClear Holdings, Inc. filed a multi-item Form 8-K on February 10, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, unregistered sales of equity securities under Item 3.02, and other events under Item 8.01, with exhibits listed under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are provided in the filing summary. No positive or negative metrics are disclosed.

Eva Live Inc8-Kneutralmateriality 3/10

10-02-2026

Eva Live Inc filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any exhibits are disclosed in the filing summary. This is a multi-item filing with limited information provided.

Reliance Global Group, Inc.8-Kneutralmateriality 8/10

10-02-2026

Reliance Global Group, Inc. filed a Form 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed. No positive or negative metrics provided, resulting in purely informational disclosure.

Valaris Ltd8-Kneutralmateriality 8/10

10-02-2026

Valaris Ltd filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, value, financial impacts, or other metrics were disclosed.

Amentum Holdings, Inc.8-Kneutralmateriality 4/10

10-02-2026

Amentum Holdings, Inc. filed an 8-K on February 10, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, numerical results, or other metrics are disclosed.

DYNAVAX TECHNOLOGIES CORP8-Kmixedmateriality 10/10

10-02-2026

Dynavax Technologies Corp filed an 8-K on 2026-02-10 disclosing entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), while also reporting completion of an acquisition or disposition of assets (Item 2.01). However, the filing includes notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures or elections of directors/officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). No financial terms, parties, or quantitative metrics were disclosed.

MCDONALDS CORP8-Kneutralmateriality 4/10

10-02-2026

McDonald's Corp filed an 8-K on February 10, 2026 (AccNo: 0000063908-26-000028, Size: 155 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or timing are disclosed.

UNIVEST FINANCIAL Corp8-Kneutralmateriality 2/10

10-02-2026

Univest Financial Corp filed an 8-K on February 10, 2026, under Item 8.01 Other Events. No specific details on the core event, financial metrics, transactions, or impacts are disclosed. No quantitative data, period-over-period comparisons, or scheduled events mentioned.

FARMERS NATIONAL BANC CORP /OH/8-Kneutralmateriality 4/10

10-02-2026

Farmers National Banc Corp /OH/ filed a Form 8-K on February 10, 2026, disclosing under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in Fiscal Year, under Item 5.07 submission of matters to a vote of security holders, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transaction values, vote outcomes, amendment descriptions, or quantitative impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no directional financial implications evident.

AMERICAN EXPRESS CO8-Kneutralmateriality 3/10

10-02-2026

AMERICAN EXPRESS CO filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transactions, financial metrics, or exhibits are provided in the filing summary. No positive, negative, or flat metrics are mentioned.

INNOVATE Corp.8-Kneutralmateriality 2/10

10-02-2026

INNOVATE Corp. filed an 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, comparisons, or directional changes are mentioned.

InvenTrust Properties Corp.8-Kneutralmateriality NOT_DISCLOSED/10

10-02-2026

InvenTrust Properties Corp. filed an 8-K on February 10, 2026, under Item 2.02 announcing Results of Operations and Financial Condition. Item 9.01 includes Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, or other quantitative data disclosed in the filing summary.

Varex Imaging Corp8-Kneutralmateriality 6/10

10-02-2026

Varex Imaging Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001681622-26-000015), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is an informational disclosure of financial results with attached exhibits.

Klaviyo, Inc.8-Kneutralmateriality 7/10

10-02-2026

Klaviyo, Inc. filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings release attachment.

  • ·AccNo: 0001835830-26-000005
  • ·Filing size: 515 KB
  • ·Sector: not specified
NMI Holdings, Inc.8-Kneutralmateriality 8/10

10-02-2026

NMI Holdings, Inc. filed a Form 8-K on February 10, 2026, under Item 2.02 announcing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard earnings-related disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing summary.

PERMIAN BASIN ROYALTY TRUST8-Kneutralmateriality 3/10

10-02-2026

Permian Basin Royalty Trust filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no directional financial data available.

La Rosa Holdings Corp.8-Kneutralmateriality 9/10

10-02-2026

La Rosa Holdings Corp. filed an 8-K on 2026-02-10 (AccNo: 0001213900-26-014257) disclosing under Item 1.01 its entry into a material definitive agreement and under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits. No specific details on deal structure, parties, valuation, terms, or financial impacts were disclosed.

MIDDLEFIELD BANC CORP8-Kneutralmateriality 5/10

10-02-2026

Middlefield Banc Corp filed an 8-K on February 10, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders (likely shareholder meeting results), Item 7.01 Regulation FD Disclosure (material non-public information voluntarily disclosed), and Item 9.01 Financial Statements and Exhibits. No specific vote outcomes, disclosure details, financial metrics, or exhibits are provided in the filing summary. This is a multi-item informational filing with no quantified positive or negative impacts disclosed.

Upstart Holdings, Inc.8-Kneutralmateriality 7/10

10-02-2026

Upstart Holdings, Inc. filed a Form 8-K on February 10, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a standard earnings-related disclosure without quantitative details available for analysis.

Upstart Holdings, Inc.8-Kneutralmateriality 5/10

10-02-2026

Upstart Holdings, Inc. filed a Form 8-K on 2026-02-10 (AccNo: 0001647639-26-000026, Size: 147 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. No specific details including key position affected (e.g., CEO, CFO), appointment or resignation status, reasons for change, named individuals, timing, or any financial metrics are disclosed. No board composition impacts, governance implications, succession signals, or market reaction data are provided.

Advanced Biomed Inc.8-K/Amateriality 4/10

10-02-2026

AMCON DISTRIBUTING CO8-Kneutralmateriality 1/10

10-02-2026

AMCON DISTRIBUTING CO filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are provided in the filing summary. All quantitative data, impacts, and strategic context are NOT_DISCLOSED.

PMGC Holdings Inc.8-Kneutralmateriality 8/10

10-02-2026

PMGC Holdings Inc. filed an 8-K on 2026-02-10 disclosing entry into a Material Definitive Agreement under Item 1.01. The filing also reports Financial Statements and Exhibits under Item 9.01. No specific details on the agreement terms, parties, financial impacts, or metrics are disclosed.

ADVANCED ENERGY INDUSTRIES INC8-Kneutralmateriality 5/10

10-02-2026

Advanced Energy Industries Inc filed an 8-K on February 10, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of quarterly or annual financial results.

INTERNATIONAL BATTERY METALS LTD.8-Kneutralmateriality 6/10

10-02-2026

INTERNATIONAL BATTERY METALS LTD. filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results alongside unregistered equity securities sales, but no specific revenue, earnings, transaction values, or quantitative metrics are provided in the filing description. No positive or negative performance indicators, period-over-period comparisons, or guidance changes are mentioned.

National Bank Holdings Corp8-Kneutralmateriality 4/10

10-02-2026

National Bank Holdings Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001475841-26-000006, Size: 9 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material information and attached exhibits, but specific details of the disclosure, financial metrics, transactions, or events are NOT_DISCLOSED.

Capital Bancorp Inc8-Kneutralmateriality 4/10

10-02-2026

Capital Bancorp Inc filed an 8-K on February 10, 2026 (AccNo: 0001419536-26-000012), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 notes financial statements and exhibits. No specific details on positions affected, individuals, reasons, timing, or quantitative impacts are disclosed.

  • ·Event Type: Officer Change
  • ·Source: us_sec
  • ·File Size: 4 MB
Marwynn Holdings, Inc.8-Kneutralmateriality 4/10

10-02-2026

Marwynn Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001213900-26-014297, Size: 231 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of the other events, financial statements, or exhibits provided. No quantitative metrics, transactions, or performance data are disclosed.

  • ·Filing date: 2026-02-10
  • ·Sector: NOT_DISCLOSED
Ivanhoe Electric Inc.8-Kneutralmateriality 8/10

10-02-2026

Ivanhoe Electric Inc. filed a Form 8-K on 2026-02-10 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.

Five Point Holdings, LLC8-Kneutralmateriality 5/10

10-02-2026

Five Point Holdings, LLC filed an 8-K on February 10, 2026, disclosing unregistered sales of equity securities under Item 3.02 and other events under Item 8.01. Item 9.01 lists financial statements and exhibits. No quantitative details such as transaction values, share counts, financial metrics, or period-over-period comparisons are provided.

Diversified Energy Co8-Kneutralmateriality 8/10

10-02-2026

Diversified Energy Co filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

EVOLUTION PETROLEUM CORP8-Kneutralmateriality 5/10

10-02-2026

Evolution Petroleum Corp filed an 8-K on February 10, 2026 (AccNo: 0001104659-26-012681), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED in the provided filing description. No period-over-period comparisons, transaction details, or scheduled events are mentioned.

GERMAN AMERICAN BANCORP, INC.8-Kneutralmateriality 4/10

10-02-2026

German American Bancorp, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or other quantitative data are disclosed in the provided filing summary. The filing has AccNo: 0000714395-26-000007 and size of 3 MB.

AMERICAN AXLE & MANUFACTURING HOLDINGS INC8-Kneutralmateriality 5/10

10-02-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on February 10, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the officer involved, position affected, reason for change, timing, financial metrics, or other quantitative data are disclosed.

  • ·Filing Accession Number: 0000947871-26-000107
  • ·Filing Size: 229 KB
Greenwave Technology Solutions, Inc.8-Kneutralmateriality 4/10

10-02-2026

Greenwave Technology Solutions, Inc. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any related compensation arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

Warner Bros. Discovery, Inc.DEFA14Amateriality 4/10

10-02-2026

AMERICAN REBEL HOLDINGS INC8-Kbearishmateriality 9/10

10-02-2026

AMERICAN REBEL HOLDINGS INC filed an 8-K on February 10, 2026, under Item 3.01 disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing. Item 3.02 reports unregistered sales of equity securities, and Item 9.01 includes financial statements and exhibits. No quantitative financial metrics, transaction values, or period-over-period comparisons were disclosed.

Rhinebeck Bancorp, Inc.8-Kneutralmateriality 3/10

10-02-2026

Rhinebeck Bancorp, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012668), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, positive or negative metrics, or strategic implications are mentioned.

NBT BANCORP INC8-Kneutralmateriality 5/10

10-02-2026

NBT Bancorp Inc filed an 8-K on February 10, 2026 (AccNo: 0001140361-26-004620, Size: 148 KB) reporting Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

CHINA PHARMA HOLDINGS, INC.8-Kneutralmateriality 8/10

10-02-2026

CHINA PHARMA HOLDINGS, INC. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.

VAALCO ENERGY INC /DE/8-Kneutralmateriality 9/10

10-02-2026

VAALCO Energy Inc. filed a Form 8-K on February 10, 2026 (event date same as filing date), reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing combining a significant transaction announcement with financial updates. No specific transaction details, financial metrics, period-over-period comparisons, dollar values, or performance directions (positive, negative, or flat) are disclosed in the provided information.

  • ·AccNo: 0000894627-26-000005; Filing size: 21 MB (suggests detailed exhibits)
  • ·Critical missing information: Filing content, agreement terms, financial metrics/revenue/earnings, balance sheet effects, guidance, dollar values, YoY/QoQ changes, scheduled events (e.g., earnings calls), named counterparties/executives, sector context - limits analysis quality to low confidence
FLYEXCLUSIVE INC.8-Kneutralmateriality 8/10

10-02-2026

FLYEXCLUSIVE INC. filed a Form 8-K on 2026-02-10 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative metrics, transaction details, parties, financial impacts, or performance comparisons provided in the summary. No positive or negative metrics are disclosed.

  • ·Filing accession number: 0001193125-26-044827
  • ·Filing size: 961 KB
  • ·Sector: NOT_DISCLOSED
Pineapple Financial Inc.8-Kneutralmateriality 4/10

10-02-2026

Pineapple Financial Inc. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

COVENANT LOGISTICS GROUP, INC.8-Kneutralmateriality 2/10

10-02-2026

COVENANT LOGISTICS GROUP, INC. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial impacts, transactions, or metrics are disclosed in the filing summary. Critical content of the events and any attached exhibits is missing, limiting assessment of materiality.

VisionWave Holdings, Inc.8-Kneutralmateriality 4/10

10-02-2026

VisionWave Holdings, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the filing summary provided.

FARADAY FUTURE INTELLIGENT ELECTRIC INC.8-Kneutralmateriality 7/10

10-02-2026

FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed an 8-K on February 10, 2026 (AccNo: 0001213900-26-014347), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing with no information on timing compliance, impacts, or guidance revisions.

MAINZ BIOMED N.V.8-Kneutralmateriality 5/10

10-02-2026

MAINZ BIOMED N.V. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events, which covers material events not specified in other items. Item 9.01 discloses Financial Statements and Exhibits, but specific details of the events or exhibits are NOT_DISCLOSED. No financial metrics, transactions, or directional impacts are provided.

Warner Bros. Discovery, Inc.SC 14D9/Amateriality 6/10

10-02-2026

MGT CAPITAL INVESTMENTS, INC.8-Kneutralmateriality 8/10

10-02-2026

MGT Capital Investments, Inc. filed a Form 8-K on 2026-02-10 disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), a multi-item mandatory filing with exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are provided. This informational disclosure lacks specifics on positive or negative effects.

  • ·AccNo: 0001493152-26-006008
  • ·File size: 195 KB
  • ·Sector: NOT_DISCLOSED
NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/8-Kneutralmateriality 3/10

10-02-2026

NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/ filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction values, financial metrics, or exhibits are provided in the filing summary. No positive, negative, or flat performance metrics are mentioned.

Celsius Holdings, Inc.8-Kneutralmateriality 5/10

10-02-2026

Celsius Holdings, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044973), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or governance implications are mentioned.

Cantor Equity Partners IV, Inc.8-Kneutralmateriality 4/10

10-02-2026

Cantor Equity Partners IV, Inc. filed an 8-K on February 10, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are disclosed. This appears to be a standard governance disclosure without additional context provided.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 82 filings

🇺🇸 More from United States

View all →
Dow Jones 30 Stocks SEC Filings — February 09, 2026 | Gunpowder Blog